Company intelligence
NS Pharma, Inc.
Transforming scientific innovation into healthier futures
About NS Pharma, Inc.
NS Pharma, Inc. (NSP) is a biopharmaceutical leader in delivering life-changing care to people living with complex, rare diseases, backed by over 100 years of Nippon Shinyaku Co. development expertise. We commercialize innovative therapies for people living with rare diseases including debilitating genetic disorders, such as Duchenne muscular dystrophy (DMD) and Hunter Syndrome. By leveraging our passionate relationships with patients, caregivers, advocacy groups, and healthcare professionals we strive to address unmet needs, understand the integrated patient journey and seize opportunities for furthering impactful innovation. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-licensing them to the world.
Verified activity
Signals from NS Pharma, Inc.
6 published signals
Presence & Recognition
NS Pharma, Inc. is participating in World Duchenne Awareness Day
Reported by NS Pharma, Inc.
Products & Services
NS Pharma, Inc. is presenting nonclinical pharmacology data on NS-863, a potential platelet-derived growth factor inhibitor for treating pulmonary arterial hypertension and interstitial lung disease.
Reported by NS Pharma, Inc.
Presence & Recognition
NS Pharma, Inc. is attending the European Respiratory Society International Congress in Barcelona for the 2026 event.
Reported by NS Pharma, Inc.
Presence & Recognition
NS Pharma, Inc. will present nonclinical pharmacology data demonstrating the pharmacological effects of NS-863 in PAH and PH-ILD animal models at the European Respiratory Society Congress in September.
Reported by NS Pharma, Inc.
Presence & Recognition
NS Pharma, Inc. presented Phase I data of NS-863, being developed for the potential treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial ung disease at the European Society of Cardiology Congress.
Reported by NS Pharma, Inc.
Presence & Recognition
NS Pharma, Inc. team connected with patients and families across the Duchenne and MPS communities this month.
Reported by NS Pharma, Inc.